跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
LAPATINIB STADA 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
LAPATINIB STADA 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Laboratorio Stada S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Aug 25, 2022
Approval ID
f2d553e01834cccc
Company
Laboratorio Stada S.L.
Type
Standard
Approval Details
Approval Id
f2d553e01834cccc
Drug Cima Aemps Name
LAPATINIB STADA 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
88047
Holder Company Name
Laboratorio Stada S.L.
Marketing Company Name
Laboratorio Stada S.L.
Authorization Date
2022-08-25
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
250 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
Yes
Company Name
Laboratorio Stada S.L.
Active Ingredients
LAPATINIB
250 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Aug 25, 2022
Approval ID
f2d553e01834cccc
Type
Standard
Back to CIMA-AEMPS Approvals
LAPATINIB STADA 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details